INVESTIGATOR-INITIATED CLINICAL TRIALS FOR NEW DRUGS IN JAPAN: CHALLENGES AND PERSPECTIVES

被引：0
|
作者：
Katsumata, N. [1 ]
机构：
[1] Musashi Kosugi Hosp Med Oncol, Nippon Med Sch, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [41] Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example
    Landewe, Robert B. M.
    Smolen, Josef S.
    Weinblatt, Michael E.
    Emery, Paul
    Dougados, Maxime
    Fleischmann, Roy
    Aletaha, Daniel
    Kavanaugh, Arthur
    van der Heijde, Desiree
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (10) : 1755 - 1760
  • [42] Effects of the 12th Amendment to the German Drug Code on Investigator-Initiated Clinical Trials
    Kehrel, U.
    GESUNDHEITSWESEN, 2011, 73 (10) : 696 - 701
  • [43] A meta-research study revealed several challenges in obtaining placebos for investigator-initiated drug trials
    Speich, Benjamin
    Logullo, Patricia
    Deuster, Stefanie
    Marian, Ioana R.
    Moschandreas, Joanna
    Heravi, Ala Taji
    Gloy, Viktoria
    Briel, Matthias
    Hopewell, Sally
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2021, 131 : 70 - 78
  • [44] Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers
    Herfarth, Hans H.
    Jackson, Susan
    Schliebe, Barbara G.
    Martin, Christopher
    Ivanova, Anastasia
    Anton, Kristen
    Sandler, Robert S.
    Long, Millie D.
    Isaacs, Kim L.
    Osterman, Mark T.
    Sands, Bruce E.
    Higgins, Peter D.
    Lewis, James D.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (01) : 14 - 22
  • [45] Investigator-initiated Randomized Controlled Trials in Infectious Diseases: Better Value for Money for Registration Trials of New Antimicrobials
    Paul, Mical
    Harbarth, Stephan
    Huttner, Angela
    Thwaites, Guy E.
    Theuretzbacher, Ursula
    Bonten, Marc J. M.
    Leibovici, Leonard
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (07) : 1259 - 1264
  • [46] EVOLUTION OF INVESTIGATOR-INITIATED CLINICAL STUDIES IN A HEALTH RESEARCH INSTITUTE
    Llanos, L.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 50 - 50
  • [47] Investigator-Initiated Registration Directed Trials, or Advanced Medical Care conducted by GOTIC and NRG-Oncology Japan
    Fujiwara, Keiichi
    ANNALS OF ONCOLOGY, 2019, 30 : 28 - 28
  • [48] Support for Investigator-Initiated Clinical Research Involving Investigational Drugs or Devices: The Clinical and Translational Science Award Experience
    Berro, Marlene
    Burnett, Bruce K.
    Fromell, Gregg J.
    Hartman, Karen A.
    Rubinstein, Eric P.
    Schuff, Kathryn G.
    Speicher, Lisa A.
    ACADEMIC MEDICINE, 2011, 86 (02) : 217 - 223
  • [49] A program to provide regulatory support for investigator-initiated clinical research
    Arbit, HM
    Paller, MS
    ACADEMIC MEDICINE, 2006, 81 (02) : 146 - 153
  • [50] "It Takes a Village" - investigator-initiated clinical trials in melanoma and non-melanoma skin cancers (NMSCs)
    Paton, Elizabeth
    Diamante, Katrina
    Economides, Alex
    Williams, Narelle
    Shackleton, Mark
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 201 - 202
12345